FierceBiotech6d
GSK drops one potential 'functional cure' for hep B as it goes all-in on bepirovirsen
GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...
phillyvoice.com5d
Philly's cure rate for hepatitis C has risen to nearly 60% over the last decade
The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.
Medscape10d
Diagnosis of Hepatitis B Virus Infection Through Serological and Virological Markers
HBsAg is the hallmark of HBV infection and is the first serological marker to appear in acute hepatitis B. Most patients recovering from acute hepatitis B clear HBsAg within 4-6 months after onset ...
The American Journal of Managed Care10d
New AGA Guidelines Recommend Risk-Based Prophylaxis for Hepatitis B Reactivation Monitoring
The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...
Healio10d
Viral hepatitis elimination requires equitable public health approach
Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...
Dose-dependent link seen for alcohol, cirrhosis, liver cancer in patients with hepatitis B
For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...
clinicaladvisor.com11d
Brelovitug Granted Breakthrough Designation for Chronic Hepatitis Delta
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).